PACS Group (PACS) Competitors $12.74 -0.18 (-1.39%) As of 10:29 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock PACS vs. RDNT, BTSG, OPCH, SHC, WGS, CON, SGRY, PRVA, HTFL, and VCYTShould you be buying PACS Group stock or one of its competitors? The main competitors of PACS Group include RadNet (RDNT), BrightSpring Health Services (BTSG), Option Care Health (OPCH), Sotera Health (SHC), GeneDx (WGS), Concentra Group Holdings Parent (CON), Surgery Partners (SGRY), Privia Health Group (PRVA), Heartflow (HTFL), and Veracyte (VCYT). These companies are all part of the "healthcare" industry. PACS Group vs. Its Competitors RadNet BrightSpring Health Services Option Care Health Sotera Health GeneDx Concentra Group Holdings Parent Surgery Partners Privia Health Group Heartflow Veracyte RadNet (NASDAQ:RDNT) and PACS Group (NYSE:PACS) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, profitability, analyst recommendations, institutional ownership, earnings, valuation and dividends. Do institutionals & insiders hold more shares of RDNT or PACS? 77.9% of RadNet shares are owned by institutional investors. 5.6% of RadNet shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Do analysts prefer RDNT or PACS? RadNet currently has a consensus target price of $76.80, suggesting a potential upside of 0.19%. PACS Group has a consensus target price of $31.00, suggesting a potential upside of 143.33%. Given PACS Group's higher possible upside, analysts clearly believe PACS Group is more favorable than RadNet.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score RadNet 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 3 Strong Buy rating(s) 3.25PACS Group 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.80 Does the media refer more to RDNT or PACS? In the previous week, RadNet had 4 more articles in the media than PACS Group. MarketBeat recorded 8 mentions for RadNet and 4 mentions for PACS Group. PACS Group's average media sentiment score of 0.78 beat RadNet's score of 0.73 indicating that PACS Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment RadNet 5 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive PACS Group 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has preferable valuation and earnings, RDNT or PACS? PACS Group has higher revenue and earnings than RadNet. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRadNet$1.91B3.09$2.79M-$0.20-383.28PACS Group$3.11B0.62$112.87MN/AN/A Which has more risk & volatility, RDNT or PACS? RadNet has a beta of 1.54, indicating that its stock price is 54% more volatile than the S&P 500. Comparatively, PACS Group has a beta of 0.89, indicating that its stock price is 11% less volatile than the S&P 500. Is RDNT or PACS more profitable? PACS Group has a net margin of 0.00% compared to RadNet's net margin of -0.78%. RadNet's return on equity of 2.41% beat PACS Group's return on equity.Company Net Margins Return on Equity Return on Assets RadNet-0.78% 2.41% 0.82% PACS Group N/A N/A N/A SummaryRadNet beats PACS Group on 9 of the 14 factors compared between the two stocks. Get PACS Group News Delivered to You Automatically Sign up to receive the latest news and ratings for PACS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PACS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PACS vs. The Competition Export to ExcelMetricPACS GroupMedical Services IndustryMedical SectorNYSE ExchangeMarket Cap$1.95B$7.72B$5.72B$21.64BDividend YieldN/A2.76%5.53%3.52%P/E RatioN/A74.1976.1629.65Price / Sales0.6234.62471.8458.92Price / CashN/A23.0337.4624.72Price / BookN/A6.8613.334.59Net Income$112.87M$245.04M$3.29B$1.00B7 Day Performance13.75%1.62%2.29%0.96%1 Month Performance6.03%2.46%4.44%3.09%1 Year Performance-68.50%10.38%75.18%14.64% PACS Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PACSPACS Group2.9917 of 5 stars$12.74-1.4%$31.00+143.3%-68.0%$1.95B$3.11B0.0032,433Upcoming EarningsRDNTRadNet3.0869 of 5 stars$74.99+1.3%$76.80+2.4%+8.6%$5.69B$1.83B-374.9311,021BTSGBrightSpring Health Services1.9271 of 5 stars$27.18+2.8%$27.10-0.3%+86.4%$4.69B$11.27B87.6835,000OPCHOption Care Health4.8684 of 5 stars$27.89-2.1%$35.75+28.2%-12.9%$4.62B$5.37B22.318,088Positive NewsAnalyst ForecastSHCSotera Health2.2161 of 5 stars$16.23+1.1%$16.00-1.4%-3.8%$4.56B$1.10B202.903,000Positive NewsWGSGeneDx2.174 of 5 stars$122.04-1.5%$104.13-14.7%+202.7%$3.56B$305.45M2,440.801,200CONConcentra Group Holdings Parent3.0936 of 5 stars$21.26-4.0%$27.50+29.3%-10.6%$2.84B$1.90B17.8711,250SGRYSurgery Partners3.1419 of 5 stars$21.60-1.2%$33.00+52.8%-32.7%$2.80B$3.11B-15.1015,000PRVAPrivia Health Group4.4176 of 5 stars$22.34-2.0%$28.58+27.9%+26.9%$2.80B$1.74B203.111,140News CoveragePositive NewsAnalyst ForecastAnalyst RevisionHTFLHeartflowN/A$32.89-1.5%$35.80+8.8%N/A$2.71BN/A0.00699News CoverageEarnings ReportAnalyst ForecastVCYTVeracyte3.5414 of 5 stars$31.87+3.2%$40.90+28.3%-0.3%$2.43B$479.13M96.58790Positive News Related Companies and Tools Related Companies RDNT Alternatives BTSG Alternatives OPCH Alternatives SHC Alternatives WGS Alternatives CON Alternatives SGRY Alternatives PRVA Alternatives HTFL Alternatives VCYT Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:PACS) was last updated on 9/24/2025 by MarketBeat.com Staff From Our PartnersWhat The Silver Boom Could Mean For You…AI, electric vehicles, and even global central banks are quietly fueling record demand for silver. This once-o...Goldco Precious Metals | SponsoredWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredRecession Risk: 90% — Are Your Savings Ready?Moody's latest report shows one-third of U.S. economic activity is already in recession or at high risk.Lear Capital | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PACS Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PACS Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.